Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
DHR
Danaher
$205.48
Chart
$189.23 (+8.59%)
$186.83 (+9.98%)
$214.81 (-4.34%)
$271.65 (-24.36%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
DHR
Danaher
Current Price
$205.48
Login to view Danaher (DHR) recommendation from the last 90 days from financial news and social media.
Chart
$189.23 (+8.59%)
$186.83 (+9.98%)
$214.81 (-4.34%)
$271.65 (-24.36%)
DHR Latest Analysis
Danaher Stock: Attractively Valued And Poised For Growth Acceleration.
Wed Jul 23, 2025
Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth Cost Discipline. )on Tuesday reported second-quarter 2025 sales of $5.94 billion up 3.5% year-over-year beating the.The life science giant reported adjusted earnings of $1.80 per share .Non-GAAP core revenue increased 1.5% year over year compared to the expectations of a growth in year over year.Operating cash flow was $1.3 billion and non-GAAPfree cash flow was $1.1 billion.Danaher'.s second-quarter adjusted operating profit margin of
Tue Jul 22, 2025
Danaher raises full-year EPS guidance to $7.70-$7.80 amid robust bioprocessing growth and portfolio resilience.
Tue Jul 22, 2025
Danaher slips despite Q2 beat as Life Sciences unit underperforms.
Tue Jul 22, 2025
Danaher (DHR) Q2 Earnings and Revenues Top Estimates. Danaher (DHR) delivered earnings and revenue surprises of 9.76% and 1.71% respectively for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Tue Jul 22, 2025
Danaher Reports Second Quarter 2025 Results. ) (the ".Company".) today announced results for the quarter ended June 27 2025.Key Second Quarter 2025 ResultsNet earnings were Revenues increased 3.5% year-over-year to Operating cash flow was Mr. Blair continued ".While the macro environment remains fluid we believe the combination of our talented team the differentiation of our portfolio and our strong financial profile will enable us to continue generating sustainable long-term value for
Tue Jul 22, 2025
Danaher Non-GAAP EPS of $1.80 beats by $0.16 revenue of $5.9B beats by $60M.
Tue Jul 22, 2025
Earnings Snapshot: Danaher surpasses Q2 estimates. raises FY25 Adj. EPS outlook.
Tue Jul 22, 2025
Danaher names new finance chief.
Tue Jul 22, 2025
Danaher Corp. Q2 Profit Decreases But Beats Estimates . (RTTNews) - Danaher Corp. (DHR) released earnings for second quarter that Decreased from the same period last year but beat the Street estimates.
Tue Jul 22, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings